ZA924966B - Vanadium complexes,process for preparing them and pharmaceutical compositions containing them - Google Patents

Vanadium complexes,process for preparing them and pharmaceutical compositions containing them

Info

Publication number
ZA924966B
ZA924966B ZA924966A ZA924966A ZA924966B ZA 924966 B ZA924966 B ZA 924966B ZA 924966 A ZA924966 A ZA 924966A ZA 924966 A ZA924966 A ZA 924966A ZA 924966 B ZA924966 B ZA 924966B
Authority
ZA
South Africa
Prior art keywords
alkyl
chemical structure
hydroxyl
formula
preparing
Prior art date
Application number
ZA924966A
Other languages
English (en)
Inventor
Jean-Michel Lacoste
Lacoste Jean-Michel
Jacques Duhault
Duhault Jacques
Denis Ravel
Ravel Denis
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA924966B publication Critical patent/ZA924966B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/005—Compounds of elements of Group 5 of the Periodic System without metal-carbon linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA924966A 1991-07-03 1992-07-03 Vanadium complexes,process for preparing them and pharmaceutical compositions containing them ZA924966B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR919108253A FR2678622B1 (fr) 1991-07-03 1991-07-03 Nouveaux complexes de vanadium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ZA924966B true ZA924966B (en) 1993-03-31

Family

ID=9414615

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA924966A ZA924966B (en) 1991-07-03 1992-07-03 Vanadium complexes,process for preparing them and pharmaceutical compositions containing them

Country Status (14)

Country Link
US (2) US5266565A (xx)
EP (1) EP0521787B1 (xx)
JP (1) JPH0742302B2 (xx)
AT (1) ATE152113T1 (xx)
AU (1) AU649849B2 (xx)
CA (1) CA2072938A1 (xx)
DE (1) DE69219221T2 (xx)
DK (1) DK0521787T3 (xx)
ES (1) ES2102478T3 (xx)
FR (1) FR2678622B1 (xx)
GR (1) GR3023940T3 (xx)
IE (1) IE922160A1 (xx)
NZ (1) NZ243418A (xx)
ZA (1) ZA924966B (xx)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637739A (en) * 1990-03-21 1997-06-10 Research Corporation Technologies, Inc. Chiral catalysts and catalytic epoxidation catalyzed thereby
ATE263770T1 (de) * 1994-02-04 2004-04-15 Smithkline Beecham Plc Verfahren zum epoxidieren prochiral olefine
US6211107B1 (en) 1994-02-04 2001-04-03 Smithkline Beecham P.L.C. Process for expoxidizing prochiral olefins and a catalyst therefor and intermediates for making the catalyst
US20020132326A1 (en) * 1995-12-15 2002-09-19 Hemmings Brian A. Process for activating a kinase
US20050053594A1 (en) * 1995-11-16 2005-03-10 Dario Alessi RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
GB9525703D0 (en) * 1995-12-15 1996-02-14 Ciba Geigy Ag Screening method
US5955111A (en) * 1996-10-08 1999-09-21 Hartford Hospital Methods and compositions for inducing production of stress proteins
US5986136A (en) * 1997-04-15 1999-11-16 President And Fellows Of Harvard College Photolabeling reagent
EP0984971A1 (en) * 1997-04-24 2000-03-15 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
US6232340B1 (en) 1997-04-24 2001-05-15 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
WO2000024730A1 (en) * 1998-10-28 2000-05-04 The University Of British Columbia Organic vanadium(iii) complexes and their use
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
EP1872797A3 (en) * 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
JP2003525303A (ja) 2000-02-29 2003-08-26 メディキュア インターナショナル インコーポレイテッド 心臓保護ホスホン酸塩およびマロン酸塩
EP1278526A2 (en) 2000-03-28 2003-01-29 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US6957781B2 (en) * 2003-09-15 2005-10-25 Kraft Food Holdings, Inc. Cleaning attachment for fluid dispenser nozzles and fluid dispensers using same
EP1773370A1 (en) * 2004-07-07 2007-04-18 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
WO2006050598A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
WO2007059631A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies
KR100722795B1 (ko) 2005-12-26 2007-05-30 한국조폐공사 초근적외선을 흡수하는 이소인돌린 비대칭 사량체환 화합물및 이를 이용한 제품
GB0607096D0 (en) * 2006-04-07 2006-05-17 Imp Innovations Ltd Compound
PL231079B1 (pl) 2012-11-07 2019-01-31 Univ Jagiellonski Kompleksy wanadu z hydrazydohydrazonami, preparaty farmaceutyczne oraz zastosowanie kompleksów wanadu z hydrazydohydrazonami
JP6735163B2 (ja) * 2016-06-22 2020-08-05 株式会社Adeka バナジウム化合物、薄膜形成用原料及び薄膜の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2619382B1 (fr) * 1987-08-11 1990-05-04 Lazaro Rene Compose organo-mineral de vanadyle, procede d'obtention d'un tel compose, composition pharmaceutique contenant ce compose organo-mineral

Also Published As

Publication number Publication date
AU1941392A (en) 1993-01-07
JPH0742302B2 (ja) 1995-05-10
ATE152113T1 (de) 1997-05-15
GR3023940T3 (en) 1997-09-30
ES2102478T3 (es) 1997-08-01
DK0521787T3 (da) 1997-10-27
DE69219221D1 (de) 1997-05-28
DE69219221T2 (de) 1997-11-20
CA2072938A1 (fr) 1993-01-04
US5278154A (en) 1994-01-11
AU649849B2 (en) 1994-06-02
US5266565A (en) 1993-11-30
NZ243418A (en) 1994-04-27
JPH05186481A (ja) 1993-07-27
IE922160A1 (en) 1993-01-13
EP0521787B1 (fr) 1997-04-23
FR2678622B1 (fr) 1994-11-18
FR2678622A1 (fr) 1993-01-08
EP0521787A1 (fr) 1993-01-07

Similar Documents

Publication Publication Date Title
AU649849B2 (en) New vanadium complexes, process for preparing them and pharmaceutical compositions containing them
IL96666A0 (en) Pharmaceutical compositions containing polyheterocyclic compounds
ES8405398A1 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
ES8605806A1 (es) Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados
FI954105A (fi) Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä
ES2149537T3 (es) Resina intercambiadora de aniones no reticulados y composicion farmaceutica que contiene la misma.
WO2002059102A3 (fr) Derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et utilisation
ES8301927A1 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
IE893653L (en) Compositions and compounds
ATE156829T1 (de) Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
IL99652A (en) Sertindole prodrugs, their preparation and pharmaceutical compositions containing them
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
HUT59665A (en) Process for producing side-chain homologues of d-vitamine derivatives and pharmaceutical compositions contianing them as active components
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
HUT68636A (en) Benzopyrane derivatives, process for producing them, and pharmaceutical compositions containing them
FI903511A0 (fi) Pyrrolo (2,1-b) tiazolderivat.
ATE97898T1 (de) Antitumor-substanz, verfahren zu deren herstellung und diese enthaltende antikrebsmittel.
MX9703112A (es) Nitro-benzamidas utiles como agentes antiarritmicos.